CV Sciences, Inc. (CVSI)
OTCMKTS: CVSI · Delayed Price · USD
0.0500
+0.0017 (3.52%)
Aug 30, 2024, 4:00 PM EDT - Market closed
CV Sciences Employees
As of December 31, 2023, CV Sciences had 43 total employees, including 42 full-time and 1 part-time employees. The number of employees decreased by 1 or -2.27% compared to the previous year.
Employees
43
Change (1Y)
-1
Growth (1Y)
-2.27%
Revenue / Employee
$368,512
Profits / Employee
-$58,791
Market Cap
9.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CVSI News
- 4 days ago - CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements - PRNewsWire
- 18 days ago - CV Sciences, Inc. (CVSI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - CV Sciences, Inc. Reports Second Quarter 2024 Financial Results - PRNewsWire
- 24 days ago - CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024 - PRNewsWire
- 3 months ago - CV Sciences, Inc. (CVSI) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - CV Sciences, Inc. Reports First Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER - PRNewsWire
- 4 months ago - CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024 - PRNewsWire